In the realm of age-related diseases, it offers hope for treating conditions like osteoarthritis, atherosclerosis, and neurodegenerative diseases
Importantly, 98% of gastrointestinal events are mild or moderate, 99.5% are non-serious, and only 4-10% of users discontinue therapy due to side effects
Expert Insight GI & Hepatology News invited Mohamed Elsaid, PhD, MPH, assistant professor in the department of biomedical informatics at The Ohio State University, to share his perspective on the studys findings
A higher incidence of allergic reactions and injection-site reactions occurred in antibody positive patients [see Warnings and Precautions (5.9)]
I was advised not to get the second dose but to get the J&J
Three things, and they deserve fair hearing